Makiko Abe

652 citations
47 papers · 395 indexed · h-index 11

Impact in

Papers in

Makiko Abe

43 papers receiving 390 citations

Peers

Makiko Abe
Comparison fields: 5 of 70
  • Nephrology 69
  • Endocrinology, Diabetes and Metabolism 109
  • Cardiology and Cardiovascular Medicine 79
  • Cancer Research 28
  • Clinical Biochemistry 12
Replace Xiaoming Tao with:
Xiaoming Tao China
Xiaobo Huang China
Soner Cander Türkiye
Paolo Fornengo Italy
Kalie L. Tommerdahl United States
Rong Luo China
Cheng‐Ching Wu Taiwan
Anna Bohdanowicz-Pawlak Poland
Vikas S. Sridhar Canada
Abhishek Kansara United States
Makiko Abe relative to Xiaoming Tao China Xiaoming Tao's profile →
Citations per field
00.5×2.7×
Xiaoming Tao · 1×
Citations per year

Countries citing papers authored by Makiko Abe

Since Specialization
Citations

This map shows the geographic impact of Makiko Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Abe more than expected).

Fields of papers citing papers by Makiko Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Abe. The network helps show where Makiko Abe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Makiko Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Makiko Abe Line = papers co-authored together Makiko Abe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20251
4 20250
5 20241
6 20249
7 20243
8 20246
9 20242
10 20245
11 20230
12 20234
13 20236
14 20233
15 20221
16 20223
17 20222
18 202210
19 202133
20 20179

About Makiko Abe

Makiko Abe is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Health and Pharmaceutical Science, having authored 47 papers that have together received 395 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (11 papers), Renal Diseases and Glomerulopathies (5 papers), COVID-19 and Mental Health (5 papers), Diabetes Treatment and Management (5 papers), Sodium Intake and Health (4 papers), Nutritional Studies and Diet (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Nephrology (69 citations), Endocrinology, Diabetes and Metabolism (109 citations), Cardiology and Cardiovascular Medicine (79 citations), Cancer Research (28 citations) and Clinical Biochemistry (12 citations). Makiko Abe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masao Toyoda, Masaaki Miyauchi, Tomoya Umezono, Naoyuki Yamamoto, Takako Kobayashi, Mayuko Kato, Moritsugu Kimura, Hisatomi Arima, Keiko Kobayashi and Daisuke Suzuki. Their work appears in journals such as Hypertension Research, Medicine, BMJ Open, Biomedicines and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026